A Cluster of Metabolic Defects Caused by Mutation in a Mitochondrial tRNA

Hypertension and dyslipidemia are risk factors for atherosclerosis and occur together more often than expected by chance. Although this clustering suggests shared causation, unifying factors remain unknown. We describe a large kindred with a syndrome including hypertension, hypercholesterolemia, and hypomagnesemia. Each phenotype is transmitted on the maternal lineage with a pattern indicating mitochondrial inheritance. Analysis of the mitochondrial genome of the maternal lineage identified a homoplasmic mutation substituting cytidine for uridine immediately 5′ to the mitochondrial transfer RNAIle anticodon. Uridine at this position is nearly invariate among transfer RNAs because of its role in stabilizing the anticodon loop. Given the known loss of mitochondrial function with aging, these findings may have implications for the common clustering of these metabolic disorders.

[1]  D. Dunger,et al.  A Family with Severe Insulin Resistance and Diabetes Due to a Mutation in AKT2 , 2004, Science.

[2]  Howard T. Jacobs,et al.  Premature ageing in mice expressing defective mitochondrial DNA polymerase , 2004, Nature.

[3]  T. Gudermann,et al.  Insights into the molecular nature of magnesium homeostasis. , 2004, American journal of physiology. Renal physiology.

[4]  R. Zager,et al.  Proximal tubular cholesterol loading after mitochondrial, but not glycolytic, blockade. , 2003, American journal of physiology. Renal physiology.

[5]  S. O’Rahilly,et al.  Minireview: human obesity-lessons from monogenic disorders. , 2003, Endocrinology.

[6]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[7]  Douglas L. Rothman,et al.  Mitochondrial Dysfunction in the Elderly: Possible Role in Insulin Resistance , 2003, Science.

[8]  V. Carelli,et al.  Pathogenic expression of homoplasmic mtDNA mutations needs a complex nuclear-mitochondrial interaction. , 2003, Trends in genetics : TIG.

[9]  M. Rodríguez-Moran,et al.  Low serum magnesium levels and metabolic syndrome , 2002, Acta Diabetologica.

[10]  Sudha Seshadri,et al.  Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. , 2002, JAMA.

[11]  C. Wollheim,et al.  Mitochondrial function in normal and diabetic β-cells , 2001, Nature.

[12]  Graeme I. Bell,et al.  Diabetes mellitus and genetically programmed defects in β-cell function , 2001, Nature.

[13]  J. Flier,et al.  A Transgenic Model of Visceral Obesity and the Metabolic Syndrome , 2001, Science.

[14]  Joseph L. Goldstein,et al.  The Cholesterol Quartet , 2001, Science.

[15]  Ali G. Gharavi,et al.  Molecular Mechanisms of Human Hypertension , 2001, Cell.

[16]  D. Levy,et al.  Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. , 1999, The New England journal of medicine.

[17]  A. Folsom,et al.  Relationship of serum and dietary magnesium to incident hypertension: the Atherosclerosis Risk in Communities (ARIC) Study. , 1999, Annals of Epidemiology.

[18]  D. Wallace.  Mitochondrial diseases in man and mouse. , 1999, Science.

[19]  P. Agris,et al.  Single atom modification (O-->S) of tRNA confers ribosome binding. , 1999, RNA.

[20]  P. Elliott,et al.  Dietary magnesium intake and blood pressure: a qualitative overview of the observational studies , 1998, Journal of Human Hypertension.

[21]  E. Marra,et al.  ATP synthesis and export in heart left ventricle mitochondria from spontaneously hypertensive rat. , 1998, International journal of molecular medicine.

[22]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[23]  S. Hunt,et al.  Familial dyslipidemic hypertension. Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension. , 1988, JAMA.

[24]  J. Neaton,et al.  Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). , 1986, JAMA.

[25]  A. Rich,et al.  Structural domains of transfer RNA molecules. , 1976, Science.

[26]  Alexander Rich,et al.  Three-Dimensional Structure of Yeast Phenylalanine Transfer RNA: Folding of the Polynucleotide Chain , 1973, Science.

[27]  D. Ellison,et al.  Mammalian distal tubule: physiology, pathophysiology, and molecular anatomy. , 2000, Physiological reviews.

[28]  R. Lifton,et al.  Gitelman's variant of Barter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na–Cl cotransporter , 1996, Nature Genetics.

[29]  L. Chambless,et al.  Frequency and clustering of nonlipid coronary risk factors in dyslipoproteinemia. The Lipid Research Clinics Program Prevalence Study. , 1986, Circulation.

[30]  E. Barrett-Connor,et al.  Clustering of heart disease risk factors in diabetic compared to nondiabetic adults. , 1983, American journal of epidemiology.